List of publications using SD 169 (Axon 1357) purchased from Axon Medchem 

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
J Yang, J He, J Wang, Y Cao, J Ling, J Qian Y Lu, H Li, Y Zheng, Y Lan, S Hong, J Matthews, MW Starbuck, NM Navone, RZ Orlowski, P Lin, LW Kwak & Q Yi.
Leukemia, 2012, 26(9), 2114-2123.
Read more: http://www.nature.com/leu/journal/v26/n9/full/leu201271a.html 

p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
J He, Z Liu, Y Zheng, J Qian, H Li, Y Lu, J Xu, B Hong, M Zhang, P Lin, Z Cai, RZ Orlowski, LW Kwak, Q Yi & J Yang.
Cancer Res. 2012, 72(24), 6393-6402.
Read more: http://cancerres.aacrjournals.org/content/72/24/6393.short  

(This is an incomplete list, created on 20-JUN-2013)